Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DB25FEGYL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,002
Award facts
- Contract value 100% obligated
- $5,002.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,002.32 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes (4 mL units). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Monovisc is a viscosupplement injection used in orthopedic care for joint pain management, reflecting AmerisourceBergen's role in supplying specialized medical commodities across multiple therapeutic domains to support military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FEGYL?
SPE2DB25FEGYL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FEGYL worth?
The government has obligated $5,002 on SPE2DB25FEGYL.
Is contract SPE2DB25FEGYL an order under another contract?
Yes. SPE2DB25FEGYL is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGYL competed?
The extent of competition for SPE2DB25FEGYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award